Economic Downturn in Biotech: Lessons From the Past
Updated October 16, 2022 In 2008-2010, the economic downturn in biotech wreaked havoc on the unprepared industry. Fast forward to late 2022, and the economic
Year: 2022
Argonaut Manufacturing Services Launches LyoDots- World’s Smallest Lyophilized Reagents
Carlsbad, CA, 7/26/22 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the biopharma, life sciences, and molecular diagnostics industries, today announced the
Argonaut Manufacturing Services Launches BioFuse Sample Prep Device, Simplifies Molecular Assays
Carlsbad, CA, 7/25/22 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the biopharma, life sciences, and molecular diagnostics industries, today announced the
Made in America: Why Molecular Diagnostic Manufacturing in the United States Makes Sense
Opinion: Wayne Woodard, CEO Argonaut Manufacturing Services In early September 2020, I wrote an opinion piece titled “Bring Manufacturing Back to the USA” that generated
FDA Gives Guidance on Transitioning EUA Status for COVID-19 Medical Devices: What You Need to Know
Getting Back to Normal Operations The FDA recently recommended that “manufacturers of devices authorized under EUA’s (to) plan now, while the pandemic is ongoing, their
n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines for Patients with Nano-rare Diseases
Argonaut to support n-Lorem’s expanding need for manufacturing of ASO therapeutics for nano-rare patients SAN DIEGO, Calif., Feb. 2, 2022, Argonaut Manufacturing Services a leading